SAN FRANCISCO – Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that using normothermic machine perfusion to preserve steatotic livers leads to altered lipid structure and metabolism and may result in more successful transplantation of these organs.
SAN FRANCISCO – Preliminary data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that pre-emptive administration of pan-genotypic, direct-acting antiviral therapy prevents chronic hepatitis C virus infection in hepatitis C-negative cardiac transplant patients who receive donor hearts infected with the virus.
Research presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – shows people in treatment for opioid substance abuse significantly lowered their non‐prescribed opioid use after testing positive for hepatitis C virus.
A new study presented this week at The Liver Meeting® — held by the American Association for the Study of Liver Diseases — found that increased utilization of split liver transplantation (sharing a donor liver between one pediatric and one adult patient) could decrease the number of children who die awaiting liver transplantation without decreasing liver transplantation access for adult patients.
Nonalcoholic fatty liver disease is associated with significantly higher risk of subsequent cardiovascular events in women, but not in men, according to research presented this week at The Liver Meeting® — held by the American Association for the Study of Liver Diseases.
Health care costs for privately insured patients with alcoholic cirrhosis are nearly twice that of non‐alcoholic cirrhosis patients in the United States, according to research presented this week at The Liver Meeting® — held by the American Association for the Study of Liver Diseases.
Serum metabolites associated with nonalcoholic fatty liver disease may be heritable, according to research presented this week at The Liver Meeting® — held by the American Association for the Study of Liver Diseases.
A new study presented this week at The Liver Meeting® — held by the American Association for the Study of Liver Diseases — found that eradication of the hepatitis C virus induced by direct‐acting antiviral medications is associated with a 71 percent reduction in the risk of liver cancer.
A new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that liver cirrhosis mortality is greater than that of five major cancers, implying the development of appropriate interventions to treat or prevent liver cirrhosis must be prioritized.
A new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that the overall number of pregnancies in women with chronic liver disease or following liver transplantation has risen over the past 30 years. In addition, the proportion of full‐term pregnancies has increased significantly over that time period, and most women had favorable pregnancy outcomes.
Herbal and dietary supplement mislabeling is common and should be evaluated as a potential cause for liver damage, according to research presented this week at The Liver Meeting® — held by the American Association for the Study of Liver Diseases.
Use of liver organs from selected hepatitis C positive donors should be considered due to modest risk of hepatitis C transmission and the availability of safe and effective direct‐acting antiviral therapies, according to research presented this week at The Liver Meeting® — held by the American Association for the Study of Liver Diseases.
A new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that daily aspirin therapy was significantly associated with a reduced risk in hepatitis B virus‐related liver cancer.
This tip sheet highlights only a few of the hundreds of abstracts being presented by members of the American Association of the Study of Liver Diseases at Digestive Disease Week, the largest international meeting of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.
Genetic factors play a role in the development of advanced alcoholic liver disease (ALD) in heavy drinkers, suggests a new study released at the American Association for the Study of Liver Diseases 2000 Annual Meeting in Dallas, October 29 -- 31.
A new study released for the first time at the American Association for the Study of Liver Diseases 1999 annual meeting suggests that the United States may soon be seeing an increase in carcinoma cases related to hepatitis C virus infection.
1- impact of race to hepatitis treatment, 2- transmission of hepatitis from mother to infant, and 3- missed diagnoses of liver disease described at the American Association for the Study of Liver Diseases Annual Meeting in Dallas Nov 5-9.
The nation's leading biomedical researchers will present breakthrough therapies and technologies in liver disease November 5 through November 9 at the 50th Annual Meeting of the American Association for the Study of Liver Diseases.
The results of the first international study of quality of life outcomes in hepatitis C conducted by the International Hepatitis Interventional Therapy Group are reported by Ware and his colleagues in the August issue of HEPATOLOGY, the monthly peer-reviewed journal of the American Association for the Study of Liver Diseases (AASLD).
A new study shows that important increases in recovery from chronic hepatitis B are obtained by prolonging the therapy up to four months, according to a study in the July issue of HEPATOLOGY.
Independent, scientific and medical expert listed below by the American Association of Liver Diseases provide commentary for reporters and medical advice for the public
New Islet Cell TRansplantation Centers Boost Research on Diabetes Cure
Organ donations have increased fivefold as families are more willing to consider organ donation. At the American Society of Transplantation Annual Scientific Meeting in Chicagoa a discussion of data on public attitudes towards donation.
At the AST Annual Scientific Meeting, researchers from Children's Hospital of Pittsburgh and St. Christopher's Hospital for Children, will discuss studies which that show that splitting livers from donors--transplanting into two recipients--can be an effective way to meet the need for donated organs.
New Drugs, New Approaches to Transplant Technologies Presented at Annual Meeting
The nation's leading transplant surgeons and researchers will present breakthrough therapies and technologies
Researchers at the American Association for the Study of Liver Diseases Annual Meeting discussed disturbing new findings indicating that interferon, the most commonly used drug against chronic Hepatitis C, is much less effective for African Americans than it is for other racial and ethnic groups.
Research that could point the way to more effective gene therapies for liver and other diseases was made public at The American Association for the Study of Liver Diseases.
At the Study of Liver Diseases 1998 Annual Meeting in Chicago, November 6 - 10, some of the world's top biomedical researchers unveiled studies of drug therapies that are offering new hope in the fight against Hepatitis.
A study presented at The American Association for the Study of Liver Diseases meeting predicts that the US could face a daunting health care burden from Hepatitis C virus infection over the next decade.
The nation's liver disease researchers will present breakthrough therapies and technologies in liver disease November 8-10 at the 49th Annual Meeting of the American Association for the Study of Liver Diseases.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right